Cargando…
Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial
BACKGROUND: Abdominal aortic aneurysm (AAA) is a slowly progressive destructive process of the main abdominal artery. Experimental studies indicate that fibrates exert beneficial effects on AAAs by mechanisms involving both serum lipid modification and favourable changes to the AAA wall. METHODS/DES...
Autores principales: | Rowbotham, Sophie E., Cavaye, Doug, Jaeggi, Rene, Jenkins, Jason S., Moran, Corey S., Moxon, Joseph V., Pinchbeck, Jenna L., Quigley, Frank, Reid, Christopher M., Golledge, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209849/ https://www.ncbi.nlm.nih.gov/pubmed/28049491 http://dx.doi.org/10.1186/s13063-016-1752-z |
Ejemplares similares
-
Randomized Placebo‐Controlled Trial Assessing the Effect of 24‐Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME‐2 Trial
por: Pinchbeck, Jenna L., et al.
Publicado: (2018) -
Health-related quality of life amongst people diagnosed with abdominal aortic aneurysm and peripheral artery disease and the effect of fenofibrate
por: Golledge, Jonathan, et al.
Publicado: (2020) -
High ankle brachial index predicts high risk of cardiovascular events amongst people with peripheral artery disease
por: Golledge, Jonathan, et al.
Publicado: (2020) -
Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): study protocol for a randomised controlled trial
por: Rowbotham, Sophie E., et al.
Publicado: (2017) -
The reproducibility of measuring maximum abdominal aortic aneurysm diameter from ultrasound images
por: Matthews, Evan O., et al.
Publicado: (2021)